BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has commended Nanomerics for the successful completion of a human study utilizing its proprietary Molecular Envelope Technology (MET).

Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The partnership aims to utilise Magnet's ...

International process systems and operation experts have launched high-tech startup Crystallization Systems Technology Inc. (CrySyst) to streamline processes used by companies in the pharmaceutical ...

The company states: “Virpax Pharmaceutical would like to congratulate Nanomerics on completing a human study using the Molecular Envelope Technology and showing no moderate to severe adverse events.

Purdue University-connected startup Molecular Intelligence supports research scientists in bioengineering, medical science ...